Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

811 result(s) found, displaying 491 to 500

PRICELINE REFLUX RELIEF EXTRA STRENGTH ranitidine 300mg (as hydrochloride) capsule-shaped tablet blister strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
PHARMACY HEALTH REFLUX RELIEF EXTRA STRENGTH ranitidine 300mg (as hydrochloride) capsule-shaped tablet blister strip pack (Suspension from the ARTG under s.29D(1)(b))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
AMCAL HEARTBURN RELIEF ranitidine (as hydrochloride) 150mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
PHARMACY CARE HEARTBURN RELIEF ranitidine (as hydrochloride) 150mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
AMCAL HEARTBURN RELIEF EXTRA STRENGTH ranitidine (as hydrochloride) 300mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
PHARMACY CARE HEARTBURN RELIEF EXTRA STRENGTH ranitidine (as hydrochloride) 300mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
CIPLA RANITIDINE 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
CIP RANITIDINE 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
RANITIDINE CA 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
RANCIP 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

28 January 2020

Cancellation or suspension

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020

Sub menu

Cipla Australia Pty Ltd

PRICELINE REFLUX RELIEF EXTRA STRENGTH ranitidine 300mg (as hydrochloride) capsule-shaped tablet blister strip pack (Extension of suspension from the ARTG under s.29E(3))

PHARMACY HEALTH REFLUX RELIEF EXTRA STRENGTH ranitidine 300mg (as hydrochloride) capsule-shaped tablet blister strip pack (Suspension from the ARTG under s.29D(1)(b))

AMCAL HEARTBURN RELIEF ranitidine (as hydrochloride) 150mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

PHARMACY CARE HEARTBURN RELIEF ranitidine (as hydrochloride) 150mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

AMCAL HEARTBURN RELIEF EXTRA STRENGTH ranitidine (as hydrochloride) 300mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

PHARMACY CARE HEARTBURN RELIEF EXTRA STRENGTH ranitidine (as hydrochloride) 300mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

CIPLA RANITIDINE 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

CIP RANITIDINE 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

RANITIDINE CA 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

RANCIP 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Extension of suspension from the ARTG under s.29E(3))

Help us improve the Therapeutic Goods Administration site

Cipla Australia Pty Ltd

Type

Date

Help us improve the Therapeutic Goods Administration site